Youcare Pharmaceutical Group Co., Ltd.
Shanghai Stock ExchangeTotal Valuation
Youcare Pharmaceutical Group Co., Ltd. carries a market capitalization of 6.48B, placing it among publicly traded companies globally. Its enterprise value stands at 7.99B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 6.48B |
| Enterprise Value | 7.99B |
Share Statistics
Youcare Pharmaceutical Group Co., Ltd. currently has 450.00M shares outstanding.
| Shares Outstanding | 450.00M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Youcare Pharmaceutical Group Co., Ltd. trades at a trailing price-to-earnings ratio of 331.84. The price-to-sales ratio is 2.84, and the price-to-book ratio stands at 11.51.
| PE Ratio | 331.84 |
| PS Ratio | 2.84 |
| PB Ratio | 11.51 |
| P/TBV Ratio | 2.82 |
| P/FCF Ratio | 32.70 |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Youcare Pharmaceutical Group Co., Ltd. trades at an EV/EBITDA multiple of 504.50 and an EV/FCF ratio of 28.08. The EV/Sales ratio of 2.66 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 504.50 provides insight into valuation relative to core operating earnings.
| EV / Sales | 2.66 |
| EV / EBITDA | 504.50 |
| EV / EBIT | 504.50 |
| EV / FCF | 28.08 |
Financial Position
Youcare Pharmaceutical Group Co., Ltd. maintains a current ratio of 1.98, meaning it holds 2.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 20.04, indicating elevated leverage, while an interest coverage ratio of 0.71 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.98 |
| Quick Ratio | 0.93 |
| Debt / Equity | 20.04 |
| Debt / EBITDA | 44.09 |
| Interest Coverage | 0.71 |
Financial Efficiency
Youcare Pharmaceutical Group Co., Ltd. posts a return on equity of -11.67 and a return on invested capital of 6.78.
| Return on Equity (ROE) | -11.67 |
| Return on Assets (ROA) | -1.68 |
| Return on Invested Capital (ROIC) | 6.78 |
| Return on Capital Employed (ROCE) | 17.03 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.04 |
Taxes
Over the trailing twelve months, Youcare Pharmaceutical Group Co., Ltd. has paid 5.44M in income taxes, reflecting an effective tax rate of 17.75.
| Income Tax | 5.44M |
| Effective Tax Rate | 17.75 |
Stock Price Statistics
Youcare Pharmaceutical Group Co., Ltd.'s stock has declined approximately -41.83633% over the past 52 weeks. The 50-day moving average sits at 16.97, while the 200-day moving average is 20.75.
| Beta (5Y) | N/A |
| 52-Week Price Change | -41.83633% |
| 50-Day Moving Average | 16.97 |
| 200-Day Moving Average | 20.75 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Youcare Pharmaceutical Group Co., Ltd. generated 3.00B in revenue and converted that into -93.67M in net income, yielding earnings per share of -0.22. EBITDA reached 15.83M, while operating income came in at 15.83M.
| Revenue | 3.00B |
| Gross Profit | 1.63B |
| Operating Income | 15.83M |
| Pretax Income | -93.44M |
| Net Income | -93.67M |
| EBITDA | 15.83M |
| EBIT | 15.83M |
| Earnings Per Share (EPS) | -0.22 |
Balance Sheet
Youcare Pharmaceutical Group Co., Ltd. holds 1.24B in cash and equivalents against 698.09M in total debt, resulting in a net debt position of -580.40M. Total book value stands at 740.72M, with working capital of 1.31B providing operational flexibility.
| Cash & Cash Equivalents | 1.24B |
| Total Debt | 698.09M |
| Net Debt | -580.40M |
| Equity (Book Value) | 740.72M |
| Book Value Per Share | 1.65 |
| Working Capital | 1.31B |
Cash Flow
After subtracting -260.83M in capital expenditures, free cash flow totaled -260.83M - equivalent to -0.58 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -260.83M |
| Free Cash Flow | -260.83M |
| FCF Per Share | -0.58 |
Margins
Youcare Pharmaceutical Group Co., Ltd. operates with a gross margin of 54.27, reflecting its pricing power and cost economics. The operating margin of 0.53 and net profit margin of -3.12 provide insight into operational efficiency.
| Gross Margin | 54.27 |
| Operating Margin | 0.53 |
| Pretax Margin | -3.12 |
| Profit Margin | -3.12 |
| EBITDA Margin | 0.53 |
Dividends & Yields
The company's payout ratio of -21.12 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.05 |
| Dividend Yield | N/A |
| Payout Ratio | -21.12 |
| Shareholder Yield | 0.15 |
| FCF Yield | 3.06 |
Scores
Youcare Pharmaceutical Group Co., Ltd. posts an Altman Z-Score of 3.87, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 3.87 |